Lotus Pharm Co Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LOTUS PHARM CO LTD, and what generic and branded alternatives to LOTUS PHARM CO LTD drugs are available?
LOTUS PHARM CO LTD has seven approved drugs.
There are two tentative approvals on LOTUS PHARM CO LTD drugs.
Drugs and US Patents for Lotus Pharm Co Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lotus Pharm Co Ltd | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 206710-003 | Feb 24, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Lotus Pharm Co Ltd | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 206710-002 | Feb 24, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Lotus Pharm Co Ltd | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 210480-006 | Mar 6, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Lotus Pharm Co Ltd | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 206710-001 | Feb 24, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Lotus Pharm Co Ltd | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 210480-005 | Mar 6, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Lotus Pharm Co Ltd | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 210480-001 | Aug 31, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Lotus Pharm Co Ltd | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090906-003 | Oct 31, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.